Want to watch better-quality PBS Video? Sign in to access higher-quality streaming!

When you sign in, you'll become a PBS Insider and we'll share your contact information with your local PBS station. You may receive updates to help you stay connected with what's happening online and in your community. Privacy Policy

Closed Captioning Settings


Captions look like this

Captions size

  • 15

Captions font family

Edge style

Captions color

Background color

Window color

Text Opacity

  • 100%

Background Opacity

  • 100%

Window Opacity

  • 0%
  • Save Settings
  • Reset


Pfizer-AstraZeneca deal could impact drug development

  • Aired: 05/03/2014
  • 02:59
  • Expires: 06/02/2014
  • Rating: NR
Pfizer's $106 billion bid for AstraZeneca has been making news this week both because of its size and suggestions that Pfizer is motivated by lower corporate tax rates overseas. But there's another question: how the possible merger might affect the development of new drugs. Shannon Pettypiece of Bloomberg joins Hari Sreenivasan for more.
Embed Options
Close ×
Pfizer-AstraZeneca deal could impact drug development
Pfizer-AstraZeneca deal could impact drug development
How might the merger of Pfizer and AstraZeneca affect the development of new drugs?
Please copy this text to your clipboard.
Problems Playing Video ?
Related Links:


Watch videos from your favorite PBS KIDS shows with the PBS KIDS Video app for your tablet or phone.

Downton Abbey Collection

Bring home the complete collection: DVDs, Blu-rays, books, gifts and more. Visit ShopPBS.


helps all of us explore new worlds and ideas. Give Now

Sponsored Links